RxDoctor Payments Data

Clayton Newell, MD

Anesthesiology · Huntsville, ALNPI 1003304288

Payments from drug & device makers

What this record shows

16 manufacturers reported payments, led by Boston Scientific at 54.7% of the total. Reporting peaked in 2023 at $6,900 and has fallen 72.0% since, to $1,930 in 2025. Among anesthesiology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,634in general payments, 2019–2025

Across 189 payments — averaging $88.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$9K
  • Medtronic$5K
  • Abbott$943
  • Biotronik NRO, Inc.$437
  • Si-bone, Inc.$172
  • Curonix LLC$145
  • plus $536 from 10 others

What the payments were for

  • Travel & lodging$7,02742%
  • Food & beverage$9,60758%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,634 in reported general payments places this provider in the 95th percentile of 484 anesthesiology providers in Alabama.

See all anesthesiology providers in Alabama

Medicare billing

Part B allowed, 2024
$174,942
Medicare patients
769
Services billed
1,838

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen526$7,861
Buprenorphine23$7,841
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen281$5,738
Gabapentin300$3,157
Pregabalin165$2,842
Nabumetone51$579
Baclofen57$478
Tramadol Hcl61$452
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen45$443
Oxycodone Hcl34$364
Morphine Sulfate20$361
Morphine Sulfate ErMorphine Sulfate15$309
Meloxicam69$262
Methocarbamol34$195
Tizanidine Hcl19$113

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Huntsville

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →